A Composite Screening Tool for Medication Reviews of Outpatients
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 24 (9) , 733-760
- https://doi.org/10.2165/00002512-200724090-00003
Abstract
Regular performance of medication reviews is prominent among methods that have been advocated to reduce the extent and seriousness of drug-related problems, such as adverse drug reactions, drug-disease interactions, drug-drug interactions, drug ineffectiveness and cost ineffectiveness. Several screening tools have been developed to guide practising healthcare professionals and researchers in reviewing the medication patterns of elderly patients; however, each of these tools has its own limitations. This review discusses a wide range of general prescription-, treatment- and patient-related issues that should be taken into account when reviewing medication patterns by implicit screening. These include generic and therapeutic substitution; potentially superfluous or inappropriate medications; potentially inappropriate dosages or duration of treatment; drug-disease and drug-drug interactions; under-treatment; making use of laboratory test results; patient adherence, experiences and habits; appropriate dosage forms and packaging. A broad selection of specific examples and references that can be used as a basis for explicit screening of medication patterns in outpatients is also offered.Keywords
This publication has 128 references indexed in Scilit:
- Potential Determinants of Drug-Drug Interaction Associated Dispensing in Community PharmaciesDrug Safety, 2005
- Repeat PrescribingDrugs, 2004
- Effects of NSAIDs on the Incidence of Hospitalisations for Renal Dysfunction in Users of ACE InhibitorsDrug Safety, 2003
- Pharmacological Management of Intermittent ClaudicationDrugs, 2000
- Drug Interactions with Tobacco SmokingClinical Pharmacokinetics, 1999
- Drug-Induced Cognitive Impairment in the ElderlyDrugs & Aging, 1999
- The Use of Sulphonylureas in the ElderlyDrugs & Aging, 1999
- Which Drugs Affect Potassium?Drug Safety, 1995
- Clinical Pharmacokinetics and Endocrine Disorders Therapeutic ImplicationsClinical Pharmacokinetics, 1987
- Influence of Thyroid Dysfunction on Drug PharmacokineticsClinical Pharmacokinetics, 1981